NTCOC
ANAC

Northern Trust Company of Connecticut’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Northern Trust Company of Connecticut’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$88K Hold
5,235
– – ﹤0.01% 1891
2013
Q3 		$56K Hold
5,235
– – ﹤0.01% 1902
2013
Q2 		$29K Buy
+5,235
New +$31.7K ﹤0.01% 1927

Other funds holding ANAC

RCP
Rho Capital Partners New York $20.4M AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Northern Trust Company of Connecticut's ANAC Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its ANACOR PHARMACEUTICALS INC COM (ANAC) position steady in Q4 2013 at 5,235 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

Northern Trust Company of Connecticut first reported a position in ANAC in Q2 2013 and has held it in 3 quarters since. 87 funds tracked by Wall St. Rank hold ANAC as of Q4 2013.

  • Northern Trust Company of Connecticut held 5,235 shares of ANACOR PHARMACEUTICALS INC COM worth $88K as of Q4 2013.
  • Northern Trust Company of Connecticut left its ANACOR PHARMACEUTICALS INC COM share count unchanged in Q4 2013.
  • ANACOR PHARMACEUTICALS INC COM made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1891 holding.
  • Northern Trust Company of Connecticut first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and has held it in 3 quarters since.
  • 87 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.